FOXN3-AS1: A Candidate Prognostic Marker and Epigenetic Target with Immunotherapeutic Implications in Acute Myeloid Leukemia.
Current medicinal chemistry
View this publicationMember
Medical Faculty, University of Bonn University Hospital of Bonn Sigmund-Freud-Strasse 25 53105 Bonn
Current medicinal chemistry
View this publicationNuklearmedizin. Nuclear medicine
View this publicationAnnals of neurology
View this publication